Search results

Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of  activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.

A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.

ANSTO has released the Independent Safety Review of Building 23 - Nuclear medicine production facility.

Award recipients Dr Richard Garrett and Dr Nigel Lengkeek with Dr Tien Pham will deliver a Distinguished Lecture on 15 November at ANSTO.

Four annual awards in neutron scattering were announced at Australian Neutron Beam Users Group (ANBUG) and AINSE Neutron Scattering Symposium (AANSS) to individuals with strong links to ANSTO

Advanced X-ray techniques have revealed new structural details about the specific arrangement of atoms in conjugated polymers, an important class of materials that are used in LEDs, organic solar cells, transistors, sensors and thermoelectric power devices.

Latest information on the scheduled supply of our nuclear medicine production.

Australian researchers and clinicians have recently returned from Japan where they investigated the use of advanced radiation therapy for cancer using heavy ions at particle therapy facilities on a study tour .

Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.